Single institution long-term efficacy and safety analysis of abiraterone acetate (AA) in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) in a named patient programme (NPP)

Detalles Bibliográficos
Autores principales: Fröbe, Ana, Murgić, Jure, Rauh, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070301/
https://www.ncbi.nlm.nih.gov/pubmed/27843608
http://dx.doi.org/10.1136/esmoopen-2016-000049
Descripción
Sumario:

Ejemplares similares